Three-dimensional Optical Surface Imaging as a Diagnostic Tool in Pectus Excavatum
NCT ID: NCT03926078
Last Updated: 2020-07-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
28 participants
INTERVENTIONAL
2019-08-21
2021-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Three-dimensional (3D) optical surface imaging offers a non-invasive, radiation-free alternative that may be used to obtain thoracic measures and determine pectus severity. However, for 3D images/scans to be used as a diagnostic tool in the proces of clinical decision making and determine surgical candidacy, its diagnostic accuracy should be evaluated. This will be investigated utilizing a pilot study design as no prior accuracy studies are available.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Patient Position on the External Haller Index Value Among Patients With Pectus Excavatum
NCT04046835
Three-dimensional Scanning of the Chest: a Comparison Between Three Different Imaging Modalities
NCT04279886
Fully Automated Scan Technique Optimisation of Scan Timing in Chest CT
NCT03658200
Radiation Dose From Computed Tomography Before and After Implementation of a High Pitch Dual Spiral Technique
NCT01111760
The Place of Imaging and Microbiology in the Diagnosis of Pneumonia in the Elderly
NCT02467192
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
CR and CT are both used as reference method, as the work-up of pectus patients in our centre is dependent of age. Subsequently, two groups are created: (A) patients under 18 years of age that receive a frontal (anteroposterior) and sagittal chest radiography, and (B) patients aged 18 years or older that receive a chest CT scan.
In this study, patients are their own control. To obtain optical surface images, a handheld 3D scanner is used. During acquisition, subjects will be standing in an upright position with arms abducted. Standard routinely used protocols are used to acquire chest radiographies and CT scans.
The HI is obtained from all chest radiographies and CT scans, calculated by dividing the widest thoracic transverse diameter by the anteroposterior distance, measured from the posterior surface of sternum to the anterior surface of the vertebral body. The EHI, a modified measurement to assess pectus deformity, is used to quantify PE severity based on 3D optical surface images. The EHI is calculated by dividing the widest external thoracic transverse diameter by the distance between the external deepest point or point of maximal protrusion and external vertebral body. The EHI is also calculated from the available chest radiographies and CT scans.
All measurements will be performed by three blinded observers that are not responsible to perform a comprehensive interpretation of the study. Following acquisition of all indices, the inter-observer reliability is calculated using the intraclass correlation coefficient. Based on the means, a receiver-operating characteristic (ROC)-curve is created for the 3D scan based EHI measurements, utilizing the surgical indication based on CR and CT (HI larger or equal to 3.25) images as gold standard. The optimal cut-off value, obtained from the ROC-curve is subsequently used to determine the 3D optical surface images' diagnostic accuracy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients under 18 years of age
Group A consists of patients that receive a chest radiography in the current work-up of PE.
3D optical surface image
3D optical surface images will be acquired and used to calculate the EHI
Chest radiography
Chest radiographies will be acquired and used to calculated the HI and EHI
Patients aged 18 years or older
Group B consists of patients that receive a CT scan in the current work-up of PE.
3D optical surface image
3D optical surface images will be acquired and used to calculate the EHI
CT scan
CT scans will be acquired and used to calculate the HI and EHI
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
3D optical surface image
3D optical surface images will be acquired and used to calculate the EHI
Chest radiography
Chest radiographies will be acquired and used to calculated the HI and EHI
CT scan
CT scans will be acquired and used to calculate the HI and EHI
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* No age restrictions were imposed, however, to be eligible, it was mandatory to be able to stand still in and upright position for 60 seconds.
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zuyderland Medisch Centrum
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zuyderland Medical Centre
Heerlen, Limburg, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
METCZ20190048
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.